Abiraterone-d4 Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White to Off-White Solid

Verwenden

Labelled Abiraterone (A108490). A steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of an drogen-dependent prostate cancer.

Abiraterone-d4 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Abiraterone-d4 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
SIMSON PHARMA LIMITED	+91-8291074273	k.das@simsonpharma.com	India	228	58
TargetMol Chemicals Inc.	+1-781-999-5354;	support@targetmol.com	United States	39037	58
R&D Scientific Inc.	+1-2266000236	sales@rdscientific.com	Canada	1941	58
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Cato Research Chemicals Inc.	020-81960175	min.he@cato-chem.com	China	1955	55
Quality Control Solutions Ltd.	0755-66853366 13670046396	orders@qcsrm.com	China	18190	56
Artis Biotech Co. Ltd.	19138486554 18108108965	sales@artisbio.com	China	2404	58
Shenzhen SUNGENING Bio-Medical Co., Ltd.	0755-28967200 13631290199	wxf@sungening.com	China	9629	60
Nanjing Haolv Biotechnology Co.,Ltd	025-84622273 17361806303	kexin.zhou@haolvbiotech.com	China	3018	58
Shenzhen Botel Biotechnology Co. Ltd.	13316949107 13316968096	1979313431@qq.com	China	9607	58

2122245-62-7()Verwandte Suche:

---

• Abiraterone-d4
• (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4
• CB 7598-d4
• 2122245-62-7
• Intermediates & Fine Chemicals
• Isotope Labelled Compounds
• Pharmaceuticals
• Steroids